Log in to save to my catalogue

Status and frontiers of Fabre disease

Status and frontiers of Fabre disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2ff878e5f49f47b49c39d42db40fe02e

Status and frontiers of Fabre disease

About this item

Full title

Status and frontiers of Fabre disease

Publisher

England: BioMed Central Ltd

Journal title

Orphanet journal of rare diseases, 2025-03, Vol.20 (1), p.123-7, Article 123

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Fabry disease is characterized by an X sex chromosome gene mutation caused by α-galactosidase A deficiency, resulting in the accumulation of globotriaosylceramide and globotriaosylsphingosine in various organs, which induces end-organ lesions. In Fabry disease, enzymes with lost or decreased activity in the body are replaced by exogenous supplement...

Alternative Titles

Full title

Status and frontiers of Fabre disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2ff878e5f49f47b49c39d42db40fe02e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2ff878e5f49f47b49c39d42db40fe02e

Other Identifiers

ISSN

1750-1172

E-ISSN

1750-1172

DOI

10.1186/s13023-025-03646-y

How to access this item